Executive Summary and Market Analysis
The North America helical CT scanner market is divided into three primary regions: the United States, Canada, and Mexico. The increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, and respiratory illnesses, necessitates accurate and timely diagnostic imaging. Additionally, the aging population in North America is driving demand for regular medical imaging, as older individuals are more likely to require such services.Technological advancements in helical CT scanners have significantly improved their effectiveness and safety. Innovations such as enhanced imaging speed, higher resolution, and reduced radiation exposure have made these devices more appealing to healthcare facilities. Furthermore, the integration of artificial intelligence (AI) and machine learning into diagnostic imaging has improved the accuracy and efficiency of scans, facilitating better clinical decision-making.
Government initiatives aimed at modernizing healthcare infrastructure, along with favorable reimbursement policies in the US and Canada, are also contributing to market growth. Increased awareness among healthcare providers and patients regarding the benefits of early diagnosis is further propelling the demand for advanced CT imaging technologies. The presence of major market players and ongoing investments in research and development for imaging technologies support continuous innovation and market penetration.
Strategic Insights
Market Segmentation Analysis
The North America Helical CT Scanner Market can be segmented based on type, slice type, and end user:
- By Type: The market is divided into Double-Layer and Multi-Layer helical CT scanners, with the Multi-Layer segment leading the market in 2024.
- By Slice Type: The segmentation includes 1-16 Slices, 17-64 Slices, 128-160 Slices, and >160 Slices, where the 17-64 Slices segment dominated in 2024.
- By End User: The market is categorized into Hospitals, Medical Centers, and Ambulatory Surgical Centers, with Hospitals being the leading segment in 2024.
Market Outlook
The helical configuration is crucial for volumetric coverage in dynamic imaging, and it works effectively with photon-counting computed tomography (PCCT). This technology enhances the efficiency of helical scans by counting individual photons and differentiating energy levels, allowing for ultra-low-dose protocols while maintaining diagnostic quality. In oncology, PCCT's superior tissue characterization improves tumor detection in helical abdominal scans by distinguishing subtle variations in iodine uptake.For instance, Siemens Healthineers' NAEOTOM Alpha is a dual-source system that supports high-speed helical acquisitions for cardiac imaging, significantly reducing motion artifacts and radiation exposure during coronary stent evaluations. By 2025, it is expected to be installed in over 100 sites globally, revolutionizing workflows in high-volume centers. The AI-driven myExam Companion automates protocol selection, enhancing the efficiency of helical scanning.
Similarly, Canon's partnership with Redlen Technologies is advancing cadmium zinc telluride (CZT)-based detectors for ultra-high-resolution helical PCCT, particularly in musculoskeletal applications where micro-fractures require sub-millimeter detail. GE HealthCare is also making strides with photon-counting prototypes that promise spectral helical imaging for neurology, improving stroke perfusion mapping with lower doses. Philips is incorporating PCCT principles into its spectral-detector helical platforms, such as the Ingenuity Elite, which enhances virtual non-contrast capabilities and reduces exam times by 23% through AI iso-centering.
In oncology, PCCT-equipped helical scanners facilitate precise tumor delineation and enhance the detection of microcalcifications, which is vital for early diagnosis and treatment planning. In cardiology, photon-counting detectors minimize blooming artifacts around stents and calcifications, improving the accuracy of coronary artery assessments. Neurology benefits from enhanced visualization of small vessels and brain structures, which is critical for evaluating strokes and trauma.
The rise of photon-counting CT technology is transforming the helical CT scanner market by providing sharper, faster, and safer imaging. This advancement supports precision medicine, catering to diverse patient needs from pediatric low-dose trauma scans to geriatric oncology surveillance. As research and development in multi-energy thresholds and AI reconstruction progress, PCCT is set to redefine helical scanning, ensuring safer and more precise diagnostic insights.
Country Insights
The North America Helical CT Scanner Market is further segmented by country, with the United States holding the largest market share in 2024. In 2023, approximately 93 million CT examinations were performed in the US, involving around 61.5 million patients, predominantly adults. With over 1.9 million new cancer cases reported annually, the demand for helical CT scans for staging and monitoring is significant, particularly for lung, breast, and prostate cancers.The American Heart Association reports nearly 919,000 cardiovascular disease deaths annually, with a substantial portion of adults diagnosed via cardiac CT angiography. The increasing prevalence of chronic respiratory illnesses and neurological disorders, coupled with lifestyle factors such as obesity and smoking, underscores the need for frequent imaging in hospitals and diagnostic centers.
Healthcare providers like the Mayo Clinic and Cleveland Clinic are integrating advanced helical CT systems from manufacturers such as GE Healthcare and Siemens Healthineers to enhance oncology screenings and cardiac assessments. These systems enable low-dose protocols that minimize patient risk while improving image quality, aligning with national guidelines from organizations like the American College of Radiology.
The integration of AI and machine learning into helical CT technology is automating image reconstruction, reducing scan times, and enhancing diagnostic accuracy. In 2025, the FDA approved Siemens' NAEOTOM Alpha, a photon-counting CT that offers spectral imaging for improved tissue differentiation, particularly beneficial for early-stage lung cancer detection.
Company Profiles
Key players in the North America Helical CT Scanner Market include Koninklijke Philips NV, Canon Inc, GE HealthCare Technologies Inc, Narang Medical Limited, Neusoft Medical Systems, FUJIFILM Holdings Corp, Siemens Healthineers AG, Shanghai United Imaging Healthcare Co., LTD, NeuroLogica Corp, and SinoVision Technology (Beijing) Co., Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.Table of Contents
Companies
The List of Companies - North America Helical CT Scanner MarketKoninklijke Philips NV
Canon Inc
GE HealthCare Technologies Inc
Narang Medical Limited.
Neusoft Medical Systems
FUJIFILM Holdings Corp
Siemens Healthineers AG
Shanghai United Imaging Healthcare Co., LTD
NeuroLogica Corp
SinoVision Technology (Beijing) Co., Ltd.

